Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
665.17
812.14
1,100.67
5,582.70
2,660.14
1,347.17
724.29
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
665.17
812.14
1,100.67
5,582.70
2,660.14
1,347.17
724.29
Raw Material Cost
449.76
516.16
521.75
1,818.23
926.26
404.69
175.69
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
186.63
0.00
0.00
0.00
233.47
156.86
134.86
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
3.19
2.28
6.10
9.92
8.63
1.42
0.32
Selling and Distribution Expenses
336.72
1,017.32
446.45
1,018.04
581.65
430.51
357.15
Other Expenses
-14.04
6.85
11.14
21.45
-13.61
-9.57
-8.25
Total Expenditure (Excl Depreciation)
835.89
1,604.23
1,085.71
3,060.65
1,613.91
897.76
585.48
Operating Profit (PBDIT) excl Other Income
-170.7
-792.0999999999999
15
2522
1046.2
449.4
138.8
Other Income
36.37
1.58
48.50
-16.71
18.29
16.31
16.62
Operating Profit (PBDIT)
20.20
-613.54
237.61
2,594.16
1,168.20
529.29
208.42
Interest
3.19
2.28
6.10
9.92
8.63
1.42
0.32
Exceptional Items
-6.30
-18.64
-1.53
-262.17
1.82
0.00
-0.17
Gross Profit (PBDT)
215.41
295.98
578.93
3,764.47
1,733.88
942.48
548.60
Depreciation
177.25
198.39
192.33
193.09
103.98
63.89
53.40
Profit Before Tax
-166.54
-832.85
37.66
2,128.99
1,057.41
463.98
154.52
Tax
12.96
117.38
-31.70
326.06
172.24
69.32
17.57
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-130.94
-654.88
140.47
1,726.00
852.16
362.66
147.29
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-130.94
-654.88
140.47
1,726.00
852.16
362.66
147.29
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-51.34
-295.47
-71.96
75.81
32.78
31.99
-10.33
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-182.28
-950.35
68.51
1,801.80
884.94
394.66
136.96
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
0.0
1.0
1.0
1.0
Reserves
3,748.35
4,109.45
4,861.28
4,907.16
3,194.38
2,390.53
1,081.72
Earnings per share (EPS)
-0.21
-1.02
0.25
2.65
1.3
0.59
0.25
Diluted Earnings per share
-0.21
-1.02
0.25
2.65
1.3
0.59
0.25
Operating Profit Margin (Excl OI)
-29.08%
-100.17%
-0.29%
43.31%
39.32%
33.34%
19.11%
Gross Profit Margin
1.61%
-78.12%
20.89%
41.59%
43.66%
39.18%
28.71%
PAT Margin
-19.69%
-80.64%
12.76%
30.92%
32.03%
26.92%
20.34%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is -18.09% vs -26.22% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 80.82% vs -1,487.45% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 97.37% vs -425.28% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 39.13% vs -62.30% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Guangdong Hybribio Biotech Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
665.17
0
665.17
Other Operating Income
0.00
0.00
0.00
Total Operating income
665.17
0
665.17
Raw Material Cost
449.76
0
449.76
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
186.63
0
186.63
Power Cost
0
0
0.00
Manufacturing Expenses
3.19
0
3.19
Selling and Distribution Expenses
336.72
0
336.72
Other Expenses
-14.04
0.00
-14.04
Total Expenditure (Excl Depreciation)
835.89
0
835.89
Operating Profit (PBDIT) excl Other Income
-170.72
0.00
-170.72
Other Income
36.37
0
36.37
Operating Profit (PBDIT)
20.20
0
20.20
Interest
3.19
0
3.19
Exceptional Items
-6.30
0
-6.30
Gross Profit (PBDT)
215.41
0
215.41
Depreciation
177.25
0
177.25
Profit Before Tax
-166.54
0
-166.54
Tax
12.96
0
12.96
Provisions and contingencies
0
0
0.00
Profit After Tax
-130.94
0
-130.94
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-130.94
0
-130.94
Share in Profit of Associates
0
0
0.00
Minority Interest
-51.34
0
-51.34
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-182.28
0
-182.28
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,748.35
0
3,748.35
Earnings per share (EPS)
-0.21
0
-0.21
Diluted Earnings per share
-0.21
0
-0.21
Operating Profit Margin (Excl OI)
-29.08%
0%
0.00
-29.08%
Gross Profit Margin
1.61%
0%
0.00
1.61%
PAT Margin
-19.69%
0%
0.00
-19.69%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 66.52 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -18.09% vs -26.22% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit -18.23 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 80.82% vs -1,487.45% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -1.62 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 97.37% vs -425.28% in Dec 2024
Annual - Interest
Interest 0.32 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 39.13% vs -62.30% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -29.08%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024






